VANCOUVER, June 13, 2011 - ISee3D Inc. (TSX-V: ICT), announced today that they reached an agreement with Hamilton Thorne Ltd. (TSX-V: HTL), a leading solutions provider in life sciences, for the development of a Single Lens 3D microscope adapter. The adapter is planned to be released in the fall of 2011. Under this agreement, Hamilton Thorne has exclusive rights to sell the ISee3D three-dimensional technology within the cell biology research markets.
The development of this 3D adapter will result in the support of 3D display by research grade microscopes currently only capable of 2D video. Both inverted and upright configurations will be supported. This adapter produces 3D through the video channel via the camera’s optical port and is optimized for use in biological research. It provides a low cost solution for this grade of camera/microscope configuration and may also be fitted with a universal adapter to support other high-powered microscopes.
“We believe this single lens 3D adapter, will be another great example of expanding the use of 3D in microscopy using ISee3D’s technology. We are privileged to have HTL’s expertise to guide us in the deployment of single lens 3D for research microscopy.” said Bruce Seidel, Business Development at ISee3D.
“Hamilton Thorne is excited to be working with the superb technical team at ISee3D. We believe that the three-dimensional capabilities of ISee3D’s technology applied to microscopy can be a real game changer in cell biology,” said Meg Spencer, Chief Executive Officer of Hamilton Thorne Ltd. “Coupled with our miniature lasers, researchers will have new capabilities in robotic micro surgery and will be able to fully visualize many types of cells, cultures and tissue sections. Further, we feel that ISee3D is well aligned with Hamilton Thorne’s vision and goals for developing ground-breaking solutions in the lab, and our technology synergies could open up new ways for researchers to see the world of cell biology.”
Hamilton Thorne's growing customer base includes pharmaceutical companies, biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Current customers include world-leading research labs such as Harvard University, MIT, Yale, McGill University, DuPont, Monsanto, Charles River Labs, Jackson Labs, Merck, Novartis, Pfizer, Oxford University, and Cambridge.